Network origin in Stephan Sigrist first degree
Entity | Entity type | Industry | |
---|---|---|---|
WMT AG
WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephan Sigrist via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Baylor College of Medicine | College/University | Doctorate Degree | |
Tsinghua University | College/University | Undergraduate Degree | |
Chinese Academy of Sciences | College/University | Graduate Degree | |
Universität Leipzig | College/University | Doctorate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Phenex Pharmaceuticals AG
Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | Pharmaceuticals: Generic | Chief Executive Officer | |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Admera Health LLC
Admera Health LLC Medical/Nursing ServicesHealth Services Admera Health LLC operates as a advanced molecular diagnostics company. Its products include PGxOne, LiquidGx, OncoGxOne, AtheroGxOne and CardioGxOne. The company was founded by Guanghui Hu in 2014 and is headquartered in South Plainfield, NJ. | Medical/Nursing Services | Chief Executive Officer | |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Chairman | |
Data Information Intelligence GmbH | Founder | ||
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor |
Statistics
International
Germany | 7 |
United States | 5 |
China | 3 |
Sectoral
Consumer Services | 5 |
Health Services | 4 |
Health Technology | 4 |
Finance | 2 |
Operational
Director/Board Member | 7 |
Founder | 5 |
Chief Executive Officer | 3 |
Chairman | 3 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Guanghui Hu | 6 |
Martin Pfister | 5 |
Claus Kremoser | 4 |
Yves Guillermet | 1 |
Siegfried Bialojan | 1 |
Julia Schaft | 1 |
Oliver Schlüter | 1 |
- Stock Market
- Insiders
- Stephan Sigrist
- Company connections